Loading...
Response to 'High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice', by Tanguay et al.
James, N ; Sydes, M ; Clarke, Noel W ; Ritchie, A ; Parmar, M
James, N
Sydes, M
Clarke, Noel W
Ritchie, A
Parmar, M
Citations
Altmetric:
Abstract
Description
Date
2016-10
Publisher
Collections
Keywords
Type
Article
Citation
Response to 'High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice', by Tanguay et al. 2016, 28 (10):666-7 Clin Oncol